Wesley Mizutani, MD, discusses California's SB 496 legislation, which addresses the crucial role of biomarkers in guiding optimal drug selection to improve overall healthcare outcomes.
Related Keywords
California , United States , Wesley Mizutani , Gavin Newsom , Alliance For Patient Access , Governor Gavin Newsom , Senate Bill , Patient Access ,
comparemela.com © 2020. All Rights Reserved.